Lewandowski K, Janicki M, Baranska M, Kandula Z, et al. Inotuzumab therapy resulted in molecular remission of relapsed/resistant B-cell acute lymphoblastic leukemia with BCR::ABL1 Lys404Glu mutation. Ann Hematol 2025 May 16. doi: 10.1007/s00277-025-06385.
PMID: 40377672